Related Experiment Videos
Gastrointestinal stromal tumors (GIST)
Hepato-Gastroenterology
|April 9, 2005
Summary
Surgical removal is the only effective treatment for gastrointestinal stromal tumors (GISTs). While most GISTs are benign and treatable with surgery, malignant cases require careful monitoring for recurrence.
Area of Science:
- Gastroenterology
- Surgical Oncology
- Oncology
Background:
- Gastrointestinal stromal tumors (GISTs) are the most common non-epithelial tumors of the digestive tract, often originating from interstitial cells of Cajal or progenitor cells.
- These tumors are frequently found in the stomach and intestines, with immunohistochemical markers including CD34 and c-kit protein (CD117).
- While two-thirds of GISTs are malignant, accurate preoperative diagnosis is challenging, occurring in only half of patients.
Purpose of the Study:
- To evaluate the outcomes of surgical intervention for gastrointestinal stromal tumors (GISTs).
- To assess the efficacy of surgical resection as the primary treatment modality for GISTs.
Main Methods:
- A retrospective analysis of 22 patients who underwent surgery for GISTs between 1996 and 2003.
- Surgical resection without extended lymphadenectomy was the preferred procedure.
Main Results:
- The study included 22 patients operated on for GISTs.
- All but one patient had benign GISTs and remained asymptomatic post-surgery.
- The single malignant case developed an irresectable local recurrence.
Conclusions:
- Gastrointestinal stromal tumors (GISTs) are rare neoplasms within the GI tract.
- Surgical removal remains the sole curative treatment option for GISTs.
- Post-operative outcomes are generally favorable for benign GISTs, but malignant cases warrant close follow-up due to recurrence risk.